The development of smart nanomedicine systems has revolutionized the field of drug delivery, offering improved precision in targeting diseased tissues and minimizing the side effects of treatments. Traditional drug delivery methods often suffer from non-specific targeting and high systemic toxicity, limiting their therapeutic potential. Smart nanomedicine systems, designed to respond to specific stimuli such as pH, temperature, or enzymes, allow for controlled and targeted drug release, thus enhancing therapeutic efficacy while reducing off-target effects. This research investigates the design, characterization, and application of smart nanomedicine systems for precision drug release and reduced toxicity. The primary objective of this study is to evaluate the efficiency of these systems in delivering drugs to specific sites, such as tumors, while minimizing damage to healthy tissues. In vitro and in vivo models are used to assess the release profiles, bio-distribution, and toxicity of the nanomedicine systems. The results show that smart nanomedicine systems significantly enhance drug accumulation at target sites and reduce systemic toxicity compared to conventional delivery methods. In conclusion, the use of smart nanomedicine systems offers a promising approach for precision medicine, improving therapeutic outcomes and reducing adverse effects associated with traditional drug delivery.